Reduction of cyclophosphamide-induced DNA damage and apoptosis effects of ginsenoside Rb1 on mouse bone marrow cells and peripheral blood leukocytes

Environmental Toxicology and Pharmacology

Volumn 27, Issue 3, 2009, Pages 384-389

  Zhang, Qiu Hua ^a,b   Wu, Chun Fu ^b   Yang, Jing Yu ^b   Mu, Yan Hua ^b   Chen, Xiao Xue ^b   Zhao, Yu Qing ^b  

^a LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anti oxidant enzyme; Apoptosis; Cyclophosphamide; DNA damage; Ginsenoside Rb1; Malondialdehyde

Indexed keywords

CYCLOPHOSPHAMIDE; GINSENOSIDE RB 1; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; COLORIMETRY; CONTROLLED STUDY; DNA DAMAGE; DRUG DOSE COMPARISON; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENOTOXICITY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

EID: 62949085359     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2009.01.001     Document Type: Article

References (59)

1. Anderson H.C., Chen H., Pellet L.T., et al. Ferousiron-induced oxidation in chicken liver slices as measured by hemichrome formation and thiobarbituric acid reactive substances: effect of dietary vitamin E and beta-carotene. Free Radic. Biol. Med. 15 (1993) 35-48
2. Anderson D., Bishop J.B., Garner R.C., et al. Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat. Res. 330 (1995) 115-181
3. Arumugam N., Sivakumar V., Thanislass J., et al. Effects of acrolein on rat liver antioxidant defense system. Indian J. Exp. Biol. 35 (1997) 1373-1374
4. Bielicki L., Voelcker G., and Hohorst H.J. Activated cyclophosphamide: an enzymc-mechanism-based suicide inactivator of DNA polymerase/3'-5' exonuclease. J. Cancer Res. Clin. Oncol. 707 (1984) 195-198
5. Boddy A.V., and Yule S.M. Metabolism and pharmacokinetics of oxazaphosphorines. Clin. Pharmacokinet. 38 (2000) 291-304
6. Brink A., Schulz B., Kobras K., et al. Time-dependent effects of sodium arsenite on DNA breakage and apoptosis observed in the comet assay. Mutat. Res. 603 (2005) 121-128
7. Bullock G., Tang C., Tourkina E., et al. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells. Exp. Hematol. 21 (1993) 1640-1647
8. Capel I.D., Leach D., and Dorrell H.M. Vitamin E retards the lipoperoxidation resulting from anticancer drug administration. Anticancer Res. 3 (1983) 59-62
9. Crook T.R., Souhami R.L., and McLean A.E. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclo-phosphamide and acrolein in human leukemia cells. Cancer Res. 46 (1986) 5029-5034
10. Daikh D.I., and Wofsy D. Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. J. Immunol. 166 (2001) 2913-2916
11. Deng H.L., and Zhang J.T. Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1. Chin. Med. J. 104 (1991) 388-395
12. Dumontet C., Drai J., Thieblemont C., et al. The superoxide dismutase content in erythrocytes predicts short-term toxicity of high-dose cyclophosphamide. Br. J. Haematol. 112 (2001) 405-409
13. Eastman A., and Barry M.A. The origins of DNA breaks: a consequence of DNA damage, DNA repair or apoptosis. Cancer Invest. 10 (1992) 229-240
14. Erickson L.C., Ramonas L.M., Zaharko D.S., et al. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro. Cancer Res. 40 (1980) 4216-4220
15. Ferguson L.R., and Pearson A.E. The clinical use of mutagenic anticancer drugs. Mutat. Res. 355 (1996) 1-12
16. Fleming R.A. An overview of cyclophosphamide and ifosfamide pharmacology. Pharmacotherapy 17 (1997) 146S-154S
17. Fraiser L.H., Kanekal S., and Kehrer J.P. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 42 (1991) 781-795
18. Fujita K., Hakuba N., Hata R., et al. Ginsenoside Rb1 protects against damage to the spiral ganglion cells after cochlear ischemia. Neurosci. Lett. 415 (2007) 113-117
19. Glazier M.G., and Bowman M.A. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch. Intern. Med. 161 (2001) 1161-1172
20. Hales B.E. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard and acrolein. Cancer Res. 42 (1982) 3016-3021
21. Healy C., Wade M., McMahon A., et al. Flow cytometric detection of tandem repeat mutations induced by various chemical classes. Mutat. Res. 598 (2006) 85-102
22. Hengstler J.G., Hengst A., Fuchs J., et al. Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1. Mutat. Res. 373 (1997) 215-223
23. Huang Z., Roy P., and Waxman D.J. Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide. Biochem. Pharmacol. 59 (2000) 961-972
24. Kaijser G.P., and Beijnen J.H. Oxazaphosphorines: cyclophosphamide and ifosfamide. In: Grochow L.B., and Ames M.M. (Eds). A Clinician's Guide To Chemotherapy Pharmacokinetics And Pharmacodynamics (1998), Williams and Wilkins, Baltimore 229-258
25. Kaya H., Oral B., Ozguner F., et al. The effect of melatonin application on lipid peroxidation during cyclophosphamide therapy in female rats. Zentralbl. Gynakol. 121 (1999) 499-502
26. Khalil W.K., Ahmed K.A., Park M.H., et al. The inhibitory effects of garlic and Panax ginseng extract standardized with ginsenoside Rg3 on the genotoxicity, biochemical, and histological changes induced by ethylenediaminetetraacetic acid in male rats. Arch. Toxicol. 82 (2008) 183-195
27. Khan S., Ramwani J.J., and O'Brien P.J. Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs. Role of lipid peroxidation. Biochem. Pharmacol. 43 (1992) 1963-1967
28. Kim J.T., Park S.H., Kim S.K., et al. Potential role of homer-2a on cutaneous vascular anomaly. J. Korean Med. Sci. 17 (2002) 636-640
29. Kubo M., Chun-Ning T., and Matsuda H. Influence of the 70% methanolic extract from red ginseng on the lysosome of tumor cells and on the cytocidal effect of mitomycin c1. Planta Med. 58 (1992) 424-428
30. Lear L., Nation R.L., and Stupans I. Effects of cyclophosphamide and adriamycin on rat hepatic microsomal glucuronidation and lipid peroxidation. Biochem. Pharmacol. 44 (1992) 747-753
31. Lee D.H., Lim B.S., Lee Y.K., et al. Involvement of oxidative stress in mutagenicity and apoptosis caused by dental resin monomers in cell cultures. Dent. Mater. 22 (2006) 1086-1092
32. Lecoeur H., Prevost M.C., and Gougeon M.L. Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V/propidium iodide assay. Cytometry 44 (2001) 65-72
33. Look M.P., and Musch E. Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy 40 (1994) 8-15
34. Mathew S., and Kuttan G. Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. J. Exp. Clin. Cancer Res. 16 (1997) 407-411
35. Matsunaga H., Katano M., Saita T., et al. Potentiation of cytotoxicity of mitomycin C by a polyacetylenic alcohol, panaxytriol. Cancer Chemother. Pharmacol. 33 (1994) 291-297
36. Mazur L., Augustynek A., and Bochenek M. Flow cytometric estimation of the plasma membrane diversity of bone marrow cells in mice treated with WR-2721 and cyclophosphamide. Toxicology 171 (2002) 63-72
37. Mirkes P.E., and Little S.A. Cytochrome c release from mitochondria of early postimplantation murine embryos exposed to 4-hydroperoxycyclophosphamide, heat shock, and staurosporine. Toxicol. Appl. Pharmacol. 162 (2000) 197-206
38. Mishra S.I., Dickerson V., and Najm W. Phytoestrogens and breast cancer prevention: what is the evidence?. Am. J. Obstet. Gynecol. 188 (2003) 66-70
39. Mythili Y., Sudharsan P.T., Selvakumar E., et al. Protective effect of dl-α-lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem. Biol. Interact. 151 (2004) 13-19
40. Nishikimi M. Oxidation of ascorbic acid with superoxide anion generated by the xanthine-xanthine oxidase system. Biochem. Biophys. Res. Commun. 63 (1975) 463-468
41. Panwar M., Samarth R., Kumar M., et al. Inhibition of benzo(a)pyrene induced lung adenoma by panax ginseng extract, EFLA400, in Swiss albino mice. Biol. Pharm. Bull. 28 (2005) 2063-2067
42. Panwar M., Kumar M., Samarth R., et al. Evaluation of chemopreventive action and antimutagenic effect of the standardized Panax ginseng extract, EFLA400, in Swiss albino mice. Phytother. Res. 19 (2005) 65-71
43. Patel J.M., Block E.R., and Hood C.I. Biochemical indices of cyclophosphamide-induced lung toxicity. Toxicol. Appl. Pharmacol. 76 (1984) 128-138
44. Patel J.M., and Block E.R. Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp. Lung Res. 8 (1985) 153-165
45. Premkumar K., Pachiappan A., Abraham S.K., et al. Effect of Spirulina fusiformis on cyclophosphamide and mitomycin-C induced genotoxicity and oxidative stress in mice. Fitoterapia 72 (2001) 906-911
46. Qiu J., Hales B.F., and Robaire B. Effects of chronic low dose cyclophosphamide exposure on the nuclei of rat spermatozoa. Biol. Reprod. 52 (1995) 33-40
47. Rekha P.S., Kuttan G., and Kuttan R. Effect of Brahma Rasayana on antioxidant systems and cytokine levels in mice during cyclophosphamide administration. J. Exp. Clin. Cancer Res. 20 (2001) 219-223
48. Rotruk J.T., Popew A.C., Ganther H.E., et al. Selenium: biochemical role as a component of glutathione peroxidase. Science 179 (1973) 588-590
49. Saito H. Effects of ginsenoside Rb1 and ginsenoside Rg1 on learning and memory. In: Shibata S., Ohtsuka Y., and Saito H. (Eds). Recent advances in ginseng studies (1990), Hirokawa Publishing Company, Tokyo 99-111
50. Sengupta S., Toh S.A., Sellers L.A., et al. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 110 (2004) 1219-1225
51. Speit G., and Hartmann A. The comet assay (singe-cell gel test). A sensitive genotoxicity test for the detection of DNA damage in individual cells. Methods Mol. Biol. 113 (1999) 203-212
52. Story M.D., Mirkovic N., Hunter N., et al. Bcl-2 expression correlates with apoptosis induction but not tumor growth delay in transplantable murine lymphomas treated with different chemotherapy drugs. Cancer Chemother. Pharmacol. 44 (1999) 367-371
53. Unnikrishnan M.C., Soudamini K.K., and Kuttan R. Chemoprotection of garlic extract toward cyclophosphamide toxicity in mice. Nutr. Cancer. 13 (1990) 201-207
54. Venkatesan N., and Chandrakasan G. Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol. Cell Biochem. 142 (1995) 79-87
55. Wang Z., Zheng Q., Liu K., et al. Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide. Basic Clin. Pharmacol. Toxicol. 98 (2006) 411-415
56. Xu S.Y., Bian R.L., and Chen X. Pharmacological Experimental Method (1991), People's Medical Publishing House, Beijing p. 1424
57. Yoon M., Lee H., Jeong S., et al. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng. Br. J. Pharmacol. 138 (2003) 1295-1302
58. Yuan Q.L., Yang C.X., Xu P., et al. Neuroprotective effects of ginsenoside Rb1 on transient cerebral ischemia in rats. Brain Res. 5 (2007) 1-12 1167
59. Zhang Q.H., Wu C.F., Duan L., et al. Protective effects of total saponins from stem and leaf of Panax ginseng against cyclophosphamide-induced genotoxicity and apoptosis in mouse bone marrow cells and peripheral lymphocyte cells. Food Chem. Toxicol. 46 (2008) 293-302